Medication Guide - 11/29/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Intron A Interferon Alfa-2b VIAL 103132 SCHERING 11/26/2021 Inrebic Fedratinib Hydrochloride CAPSULE;ORAL 212327 IMPACT 11/23/2021 Ultomiris Ravulizumab-Cwvz INJECTABLE;INJECTION 761108 ALEXION PHARM 11/22/2021 Suboxone Buprenorphine Hydrochloride; Naloxone Hydrochloride TABLET;SUBLINGUAL 020733 INDIVIOR INC 11/19/2021 Suboxone Buprenorphine Hydrochloride; Naloxone Hydrochloride FILM;BUCCAL, SUBLINGUAL 022410 INDIVIOR INC 11/19/2021 Subutex Buprenorphine Hydrochloride TABLET;SUBLINGUAL 020732 INDIVIOR INC 11/19/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA